Hints and tips:
Related Special Reports
...Bayer has been ensnared in a US legal battle over Monsanto’s weedkiller Roundup, whose active ingredient glyphosate has been blamed by tens of thousands of Americans for giving them cancer....
...These are largely, but not exclusively, a legacy of its $63bn acquisition of US crops company Monsanto in 2016....
...It is hard to see how he can climb out of the morass without selling or spinning off the company’s consumer health division, despite Bayer long resisting calls for a break-up....
...The company had almost €39bn in net financial debt at the end of September. Bayer’s woes have not been confined to the fallout from the Monsanto transaction....
...Investors have sent the company’s shares to their lowest level in 19 years following Anderson’s decision to ditch immediate break-up plans for the company on Tuesday....
...from the fallout of its ill-fated $63bn takeover of US seeds-maker Monsanto in 2016, which saddled the company with billions in debt and exposed it to costly litigation over Roundup....
...The decision marks one of the biggest Roundup losses for Bayer, which acquired Roundup when it completed its acquisition of Monsanto in 2018....
...The company is suffering from a sprawling multibillion litigation over its weedkiller glyphosate in the US, which it acquired in its controversial 2016 acquisition of US rival Monsanto and which former users...
...Despite that, the company has taken steps to end the protracted crisis over Roundup, which Bayer acquired as part of its ill-fated $63bn acquisition of US crop sciences business Monsanto in 2016....
...Bayer is under pressure from shareholders as it is reeling from the $63bn acquisition of US crop science giant Monsanto....
...Shares in Bayer have underperformed since the group’s €63bn takeover of US agrochemical giant Monsanto, which saddled the company with debt and exposed it to costly and drawn-out litigation over allegations...
...But the deal, masterminded by Bayer’s former chief Werner Baumann, has instead saddled the German company with debt and a vast legal fight in the US over Monsanto’s allegedly carcinogenic weedkiller Roundup...
...Over the weekend, Bayer also lost a key court case in the US on weed killer Roundup, which it acquired via its merger with Monsanto....
...The company is still reeling from its ill-fated $63bn takeover of the US seeds maker Monsanto in 2016....
...Bayer’s 2018 acquisition of US crop science company Monsanto is the takeover that just keeps on taking. This week’s €2.5bn impairment charge adds to already extensive financial damage....
...Bayer’s portfolio through the German group’s 2016 acquisition of Monsanto, for their cancer....
...Bayer has lost a lot of ground since its disastrous 2018 acquisition of Monsanto. Bill Anderson, who became chief executive in June, describes it as bogged down in litigation, bureaucracy and debt....
...Lex has been following the travails of Bayer and the fallout from its disastrous acquisition of Monsanto in 2016....
...At the other end of the spectrum, Bayer has so far paid $20bn for lawsuits related to its acquisition of Monsanto and the allegedly carcinogenic properties of its glyphosate herbicide....
...With a stock market value of just €51bn, the company is currently worth less than Bayer on its own before the Monsanto acquisition....
...The company will report second-quarter results on August 8....
...Bayer turned the tables on Monsanto and bought the US company in a $63bn transaction that now ranks as one of the most disastrous takeovers....
...The company has been reeling from the billions in debt it took on to acquire Monsanto and the mounting costs around the crop company’s weedkiller glyphosate litigation cases....
...Quick links to Lex A troubled trio for you: Bayer has a big week approaching....
International Edition